Moneycontrol
HomeNewsWorldMore than 1,000 queue for food in rich Geneva amid coronavirus shutdown
Trending Topics

More than 1,000 queue for food in rich Geneva amid coronavirus shutdown

The line of people stretched for more than 1 km (half a mile) outside an ice rink where volunteers were handing out around 1,500 parcels to people who started queuing as early as 5 am.

May 09, 2020 / 20:18 IST
Story continues below Advertisement

More than 1,000 people queued up on Saturday to get free food parcels in Geneva, underscoring the impact of the coronavirus epidemic on the working poor and undocumented immigrants even in wealthy Switzerland.

The line of people stretched for more than 1 km (half a mile) outside an ice rink where volunteers were handing out around 1,500 parcels to people who started queuing as early as 5 am.

Story continues below Advertisement

"At the end of the month, my pockets are empty. We have to pay the bills, the insurance, everything," said Ingrid Berala, a Geneva resident from Nicaragua who works part-time. "This is great, because there is food for a week, a week of relief...I don't know for next week."

In a nation of nearly 8.6 million, 660,000 people in Switzerland were poor in 2018, charity Caritas says, particularly single parents and those with a low level of education unable to find work after losing a job.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show